Kushner, B. H., K. Kramer, S. Modak and N. K. Cheung (2006). "Irinotecan plus temozolomide for relapsed or refractory neuroblastoma." J Clin Oncol 24(33): 5271- 5276. Ph III Ewing’s Sarcoma Vigil ± Irinotecan +Temozolomide IND 014205 CL-PTL-130 Version: 03 Page 71 of 74 Confidential and proprietary information of Gradalis, Inc. Effective: 05-DEC-2018 It is the user’s responsibility to verify adequate training before executing a document. Do not make unauthorized copies. 28. Ladenstein, R., U. Pötschger, M. C. Le Deley, J. Whelan, M. Paulussen, O. Oberlin, H. van den Berg, U. Dirksen, L. Hjorth, J. Michon, I. Lewis, A. Craft and H. Jürgens (2009). "A prognostic score at diagnosis for Ewing tumor patients with metastatic disease at extrapulmonary sites." J Clin Oncol 27: 10544. 29. Leavey, P. J. and A. B. Collier (2008). "Ewing sarcoma: prognostic criteria, outcomes and future treatment." Expert Rev Anticancer Ther 8(4): 6 17-624. 30.